DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleau, A.-M.
Right arrow Articles by du Souich, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleau, A.-M.
Right arrow Articles by du Souich, P.

Vol. 29, Issue 7, 1007-1012, July 2001

SHORT COMMUNICATION

Cytochrome P450 Down-Regulation by Serum from Humans with a Viral Infection and from Rabbits with an Inflammatory Reaction


    Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Serum from humans with an upper respiratory viral infection (HSURVI) and from rabbits with a turpentine-induced acute inflammatory reaction (RSTIAR) reduces the activity of hepatic cytochrome P450 (P450) following 4 h of incubation. The aim of the present study was to assess the effect of HSURVI and RSTIAR on P450 activity and expression following 24 h of incubation with hepatocytes from control (HCONT) and rabbits with a TIAR (HINFLA). RSTIAR incubated with HCONT for 24 h reduced P450 content and activity, and CYP3A6 by 45%, without changing CYP1A1 and 1A2; when incubated with HINFLA, RSTIAR decreased P450 content and activity without affecting CYP1A1 or 1A2. HSURVI incubated for 4 h with HCONT decreased P450 activity without affecting the amounts of CYP1A1, 1A2, or 3A6, although when incubated for 24 h, P450 activity and CYP3A6 amount decreased. HSURVI incubated with HINFLA for 4 h reduced P450 content and activity, and incubated for 24 h reduced activity, P450 content, and amount of CYP1A1 and 1A2 proteins. The present study demonstrates that 1) the effect of RSTIAR and HSURVI depends upon the susceptibility of the hepatocyte, i.e., HCONT or primed HINFLA; 2) P450 down-regulation is preceded by a decrease in P450 activity; 3) the nature of the inflammatory reaction determines the repercussions on P450 activity and expression; and 4) CYP3A6 is more vulnerable than CYP1A1 and 1A2 to the down-regulation provoked by an inflammatory challenge.


    Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In human, viral and bacterial infections as well as influenza and BCG vaccinations decrease the clearance of exogenous substances such as theophylline and antipyrine, secondary to a decrease in activity of multiple isoforms of the cytochrome P450 (P4501) (Morgan, 1997). As a consequence, bacterial and viral inflammatory reactions are cause of severe drug toxicity, essentially in pediatric and geriatric populations (Hendeles et al., 1977; Ziment, 1982; Koren and Greenwald, 1985). In animal models, infectious and noninfectious acute inflammatory reactions, such as those induced by endotoxin and turpentine, also diminish the rate of metabolism of xenobiotics (Parent et al., 1992; Morgan, 1997).

In response to viral infections, the concentration in blood of many cytokines is increased (Ramshaw et al., 1997). It has been assumed that in vivo cytokines are responsible for P450 depression because in vitro cytokines can depress multiple hepatic P450 isoforms and their mRNAs. For instance, INF-gamma depresses CYP1A2, 2A6, 2B6, and 3A4; IL-6 depresses CYP1A1, 1A2, 2D, 3A4, and 4A1; and IL-1beta down-regulates 1A2, 2C11, 2D6, 2E1, and 3A (Fukuda et al., 1992; Trautwein et al., 1992; Donato et al., 1997; Parmentier et al., 1997). Furthermore, it has been reported that IFN-alpha (Stanley et al., 1991), IL-1 (Peterson and Renton, 1986), and TNF-alpha (Paton and Renton, 1998) can also reduce the activity of several P450 isoforms.

In vitro, following an incubation period of 4 h with hepatocytes, serum from humans with an upper respiratory tract viral infection (HSURVI) and serum from rabbits with a turpentine-induced acute inflammatory reaction (RSTIAR) decreases the activity of CYP1A1 and 1A2 without affecting the amount of these proteins (El-Kadi et al., 1997). The mediators responsible for the decrease in P450 activity are IFN-gamma , IL-6, and IL-1beta in HSURVI, and IL-6 in RSTIAR (Bleau et al., 2000), demonstrating that in vivo, infectious, and noninfectious inflammatory reactions generate serum mediators, namely, cytokines, capable to reduce P450 activity.

Since in vivo, an inflammatory reaction depresses the expression of multiple isoforms of the P450, it was of interest to establish whether HSURVI and RSTIAR are capable to down-regulate the expression of selected P450 isoforms in hepatocytes. Specifically, the aims of the present study were 1) to assess the effect of RSTIAR and HSURVI on the activity and expression of hepatic CYP1A1, 1A2, and 3A6 following 24-h incubation periods; and 2) to compare the differences in effect between RSTIAR and HSURVI as a function of the source of the hepatocytes, i.e., hepatocytes harvested from control rabbits (HCONT) and hepatocytes from rabbits with a TIAR (HINFLA). The use of HINFLA was justified because the density of surface receptors to cytokines is greater than in HCONT (Dinarello, 1994). Theophylline was used to assess the activity of some isoforms of the P450. In the rabbit, theophylline is primarily metabolized by CYP1A2 and CYP1A1, and to a minor degree by CYP3A6; CYP1A1, and CYP1A2 both contribute to the formation of theophylline three metabolites 3-methylxanthine (3 MX), 1-methyluric acid (1 MU), and 1,3-dimethyluric acid (1,3DMU) (Kurdi et al., 1999).



    Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Collection of Hepatocytes and Serum from Rabbits. Male New Zealand White rabbits (1.8-2.2 kg) were obtained from Ferme Charles Rivers (St-Constant, Québec, Canada). A local inflammatory reaction was induced by the s.c. injection of 5 ml of turpentine (Recochem, Montréal, Québec) distributed into four distinct sites of the back of the rabbits. Forty-eight hours later, blood (20 ml) was withdrawn from the central artery of an ear of the rabbits, controls and with a TIAR; the rabbits were anesthetized, and hepatocytes were isolated. Blood samples were allowed to clot at room temperature for 2 h, centrifuged at 2500 rpm for 5 min, and the serum was decanted and stored frozen at -20°C in 1-ml aliquots until use. The severity of the inflammatory reaction was assessed by measuring serum concentrations of seromucoids (Parent et al., 1992). All the experiments were conducted according to the Canadian Council on Animal Care guidelines for use of laboratory animals.

Hepatocytes were isolated according to the two-step liver perfusion method of Seglen (1976), with minor modifications (El-Kadi et al., 1997). Viability was over 90% as assessed by trypan blue exclusion, and cell concentration was adjusted to 4 × 106/ml with Williams' medium E supplemented with 10% calf serum. Aliquots of 2 ml of the hepatocytes, i.e., 8 × 106 cells, in suspension were transferred into each well of 12-well plastic culture plates (Falcon; Becton Dickinson Labware, Rutherford, NJ) coated with type I rat tail collagen and incubated with serum from control rabbits (RSCONT) and RSTIAR for 4 and 24 h at 37°C in an atmosphere of 95% O2, 5% CO2. Cell culture was conducted under sterile conditions.

Collection Serum from Humans. Blood (10 ml) was withdrawn from humans (n = 8) with an inflammatory reaction secondary to an upper respiratory viral infection, at the apex of clinical symptomatology, i.e., 24 h after the appearance of overt manifestations of an upper respiratory tract viral infection, such as rhinorrhea, sneezing, nasal congestion, sore throat, cough, and systemic signs of malaise, including fever, in absence of purulent secretions. Blood samples were allowed to clot at room temperature for 2 h, centrifuged at 2500 rpm for 5 min, and the serum was decanted and stored frozen at -20°C in 1-ml aliquots until use.

Five of the volunteers with an upper respiratory viral infection, once the blood sample was withdrawn, took 300 mg of theophylline orally, and urine was collected for 24 h. At least 2 months later, in absence of any sign of infectious disease, a blood sample of 10 ml was withdrawn from the same five volunteers who subsequently received orally a second dose of 300 mg of theophylline, and urine was collected for 24 h. Serum from healthy volunteers (HSCONT) and HSURVI were incubated with HCONT and HINFLA and its effect on total P450 content and theophylline metabolism was assessed. Theophylline and its metabolites were assayed in the 24-h urine collections.

Cytochrome P450 Content and Activity. The efficacy of the serum to reduce hepatic P450 content was tested by incubating 200 µl of serum with 2 ml/well of HCONT and HINFLA for 4 and 24 h. Hepatic P450 content, evaluated by its ability to bind carbon monoxide, was measured spectrophotometrically as described by Omura and Sato (1964). Protein content in hepatocytes was measured by the method of Lowry et al. (1951).

To assess the effect of serum on the activity of CYP1A1, 1A2, and 3A6 we determined the ability of P450 to metabolize theophylline by measuring the concentration of theophylline metabolites 3 MX, 1 MU, and 1,3DMU generated after 4 and 24 h of incubation (Kurdi et al., 1999). Theophylline was dissolved in serum-free Williams' medium E, and 100 µl was added to each well containing the hepatocytes to attain a final concentration of 176 µM. After 4 and 24 h of incubation, an aliquot of the medium was collected and frozen at -20°C until analysis of theophylline and its metabolites by high-performance liquid chromatography (du Souich et al., 1989).

Western Blot Analysis. Proteins were separated by SDS-polyacrylamide gel electrophoresis (7.5% polyacrylamide) under nonreducing conditions (Smith, 1994). Proteins were electrophoretically transferred to a nitrocellulose membrane using a semidry transfer process (Bio-Rad, Hercules, CA). CYP1A1 and 1A2 proteins were detected with a polyclonal anti-rabbit CYP1A1, and visualized with an alkaline phosphatase-conjugated secondary goat antibody using nitro blue tetrazolium as the substrate (Kruger, 1994). CYP3A6 protein was detected with a monoclonal anti-rat CYP3A1 and a horseradish peroxidase-conjugated secondary antibody; chemiluminescence was visualized by autoradiography (Thorpe et al., 1985). The intensities of the bands were measured with a software Un-Scan-It-Gel (Silk Scientific Inc., Orem, UT).

Drugs and Chemicals. The Percoll gradient, Williams' medium E, calf serum, type I rat tail collagen, NaCl, KCl, KH2PO4, HEPES, EGTA, glucose, theophylline, 3 MX, 1 MU, and 1,3DMU were purchased from Sigma (St. Louis, MO) and insulin was from Roche Molecular Biochemicals (Mannheim, Germany).

Statistical Analysis. All data are reported as means ± S.E. The comparison of the results from the various experimental groups and their corresponding controls was carried out using a one-way analysis of variance followed by Newman-Keuls post hoc test. The effect of RSTIAR and HSURVI on the amount of CYP1A1, 1A2, and 3A6 (densitometry values) was compared with the effect of RSCONT and HSCONT by using a paired t test. The differences were considered significant when p < 0.05.



    Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Effect of a TIAR on P450 Content, Activity, and Amount of P450 Apoproteins. Total P450 content in HCONT was 0.284 ± 0.014 nmol/mg of protein, a value that was reduced to 0.152 ± 0.012 nmol/mg of protein in HINFLA (p < 0.05). Compared with HCONT, when theophylline was incubated for 4 h with HINFLA, the formation of 1,3DMU, 3 MX, and 1 MU was reduced by 43, 85, and 43%, respectively (p < 0.005), reflecting essentially a decrease in CYP1A1 and 1A2 activity (Table 1). After 24 h of incubation, the formation of 1,3DMU, 3 MX, and 1 MU was reduced by a percentage similar to that reported after 4-h incubation (data not shown). Compared with HCONT, the TIAR diminished the amount of CYP1A1 by 47%, i.e., densitometry values were 391,687 ± 41,243 in HCONT and 207,492 ± 30,617 in HINFLA (n = 3, p < 0.05). CYP1A2 densitometry values were 309,098 ± 57,205 in HCONT and 205,618 ± 35,456 in HINFLA (n = 3, p > 0.05). The amount of CYP3A6 apoprotein was reduced to an undetectable level (Fig. 1).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1
Effect of serum from rabbits with an inflammatory reaction on P450 content and ability to biotransform theophylline incubated for 4 and 24 h with hepatocytes from control rabbits

Hepatocytes from control rabbits (HCONT) (n = 8) and hepatocytes from rabbits with a turpentine-induced inflammatory reaction (HINFLA) (n = 8) were incubated with NaCl 0.9% for 4 h or with serum from control rabbits (RSCONT) and serum from rabbits with an inflammatory reaction (RSTIAR) (n = 8) for 4 and 24 h.


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of a turpentine-induced inflammatory reaction on the amount of CYP1A1, 1A2, and 3A6 apoproteins in hepatocytes from control (HCONT) and rabbits with a turpentine-induced inflammatory reaction (HINFLA), 48 h after the injection of turpentine.

Numbers indicate densitometry values.

Effect of RSCONT and RSTIAR on P450 of HCONT Following 4 and 24 h of Incubation. Incubation of RSCONT with HCONT for 4 h did not modify P450 content and ability to biotransform theophylline (n = 7) (Table 1). Compared with RSCONT, RSTIAR did not modify P450 content, and did not reduce the formation of 3 MX, 1 MU, and 1,3DMU (p > 0.05) (Table 1). Neither RSCONT nor RSTIAR affected the amount of CYP1A1, 1A2, and 3A6 apoproteins in HCONT (data not shown).

After a 24-h period of incubation with HCONT, compared with RSCONT, RSTIAR did not modify P450 content, but reduced the formation of 1 MU and 1,3DMU by 27 and 28%, respectively (p < 0.05, n = 8) (Table 1). Following 24 h of incubation with RSTIAR, the amount of CYP1A1 and 1A2 remained unchanged, i.e., densitometry values for CYP1A1 were 283,835 ± 17,818 incubated with RSCONT and 277,457 ± 19,912 with RSTIAR, and for CYP1A2 densitometry values were 305,303 ± 60,486 with RSCONT and 327,771 ± 79,745 with RSTIAR. On the other hand, by reference to RSCONT (densitometry value 492,585 ± 98,749), CYP3A6 decreased by 45% when HCONT was incubated with RSTIAR (284,232 ± 68,265) (n = 4, p < 0.05) (Fig. 2).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of serum from control (RSCONT) and rabbits with a turpentine-induced inflammatory reaction (RSINFLA) on the amount of CYP1A1, 1A2, and 3A6 apoproteins in hepatocytes from control rabbits (HCONT) and rabbits with a turpentine-induced inflammatory reaction (HINFLA), after a 24-h period of incubation.

Numbers indicate densitometry values.

Effect of RSCONT and RSTIAR on P450 of HINFLA Following 4 and 24 h of Incubation. Following 4 h of incubation, and compared with RSCONT, RSTIAR did not reduce P450 content in HINFLA, but reduced the formation of 1 MU and 1,3DMU by 34 and 26%, respectively (p < 0.005, n = 7) (Table 2). On the other hand, the amount of CYP1A1 and 1A2 proteins was not affected in HINFLA (data not shown).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2
Effect of serum from rabbits with an inflammatory reaction on P450 content and ability to biotransform theophylline incubated for 4 and 24 h with hepatocytes from rabbits with a turpentine-induced inflammatory reaction

Hepatocytes from rabbits with a turpentine-induced inflammatory reaction (HINFLA) (n = 7) were incubated with serum from control rabbits (RSCONT), and serum from rabbits with an inflammatory reaction (RSTIAR) (n = 7) for 4 and 24 h. Data are means ± S.E.

Following 24 h of incubation, RSTIAR decreased P450 content by 36% (Table 2), and reduced the rate of formation of 3 MX, 1 MU, and 1,3DMU by 36, 49, and 36%, respectively (p < 0.005, n = 7) (Table 2). Following 24 h of incubation with RSTIAR, the amount of CYP1A1 and 1A2 remained unchanged, i.e., densitometry values for CYP1A1 were 204,011 ± 15,778 incubated with RSCONT and 201,612 ± 19,225 with RSTIAR, and for CYP1A2 densitometry values were 218,437 ± 27,978 with RSCONT and 228,921 ± 40,541 with RSTIAR (n = 4). Since in HINFLA the amount of 3A6 apoprotein was not measurable, it was not possible to assess the effect of RSTIAR (data not shown). The percentage of reduction for each metabolite is greater at 24 h than at 4 h (p < 0.05).

In Vivo Effect of an URVI on Metabolism of Theophylline in Human Volunteers. During the symptom-free period in five control volunteers, the 24-h urinary recovery of theophylline and its metabolites accounted for 69% of the dose administered, of which 13.3% was 3 MX, 20.3% 1 MU, and 52.5% was 1,3DMU. While the volunteers presented symptoms of URVI, the 24-h urinary recovery of theophylline and its metabolites decreased to 58% (p < 0.05). Compared with the control period, recovery of 3 MX, 1 MU, and 1,3DMU was decreased by 30, 29, and 14% (p < 0.05), respectively (Fig. 3).


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3.   Amount of 3 MX, 1 MU, and 1,3DMU recovered in a 24-h urinary collection from five volunteers with and without an upper respiratory viral infection after oral intake of 300 mg of theophylline.

Effect of HSCONT and HSURVI on P450 of HCONT Following 4 and 24 h of Incubation. Incubation of HSCONT with HCONT for 4 and 24 h did not change hepatic P450. In contrast, following 4 h of incubation, HSURVI did not modify total P450 content but decreased the formation of 1 MU and 1,3DMU by 28 and 32%, respectively (p < 0.05) (Table 3). The amounts of CYP1A1, 1A2, and 3A6 were not affected (data not shown).

                              
View this table:
[in this window]
[in a new window]
 

TABLE 3
Effect of serum from control subjects (HSCONT) and volunteers with an upper respiratory tract viral infection reaction (HSURVI) on the ability of hepatocytes from control rabbits (HCONT) and rabbits with a turpentine-induced inflammatory reaction (HINFLA) to biotransform theophylline after a 4- and 24-h period of incubation

Results are mean ± S.E.

Following 24 h incubation of HCONT with HSURVI, P450 content did not change, but the concentration of 3 MX, 1 MU, and 1,3DMU decreased by 27, 38, and 36% (p < 0.05), respectively (Table 3). Under these experimental conditions, incubation with HSURVI, the amount of CYP1A1 and 1A2 remained unchanged, i.e., densitometry values for CYP1A1 were 234,567 ± 19,489 incubated with HSCONT and 199,592 ± 43,628 with HSURVI, and for CYP1A2 densitometry values were 297,137 ± 45,563 with HSCONT and 258,061 ± 53,162 with HSURVI (n = 4). The amount of CYP3A6 was reduced by 56% from 453,518 ± 134,833 to 214,747 ± 85,175 (n = 4, p < 0.05) (Fig. 4).


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of serum from volunteers with (HSURVI) and without (HSCONT) an upper respiratory tract viral infection reaction on the amount of CYP1A1, 1A2, and 3A6 apoproteins in hepatocytes from control rabbits (HCONT) and rabbits with a turpentine-induced inflammatory reaction (HINFLA), after a 24-h period of incubation.

Numbers indicate densitometry values.

Effect of HSCONT and HSURVI on P450 of HINFLA Following 4 and 24 h of Incubation. Incubation of HSURVI with HINFLA for 4 h decreased total P450 content from 0.140 ± 0.013 nmol/mg of protein to 0.101 ± 0.011 nmol/mg of protein (p < 0.05). HSURVI lowered the concentration of 1 MU and 1,3DMU by 42 and 32%, respectively (p < 0.05) (Table 3), without affecting the amount of CYP1A1 and 1A2 (data not shown).

Incubation of HSURVI with HINFLA for 24 h decreased total P450 content from 0.135 ± 0.011 nmol/mg of protein to 0.079 ± 0.009 nmol/mg of protein (p < 0.05) (n = 7), and lowered the concentration of 3 MX, 1 MU, and 1,3DMU by 40, 55, and 39%, respectively (p < 0.05) (n = 7) (Table 3). Following incubation with HSURVI, the amounts of CYP1A1 and 1A2 were reduced by 33 and 22% (p < 0.05), respectively, i.e., densitometry values for CYP1A1 were 193,520 ± 12,936 incubated with HSCONT and 125,503 ± 10,377 with HSURVI, and for CYP1A2 densitometry values were 188,124 ± 17,748 with HSCONT and 141,281 ± 10,405 with HSURVI (n = 4) (Fig. 4).

Considering the five volunteers who received 300 mg of theophylline, incubation of HSURVI with HINFLA for 4 h reduced theophylline biotransformation and P450 content (data not shown), decrease that was not associated with the decrease in 24-h urinary recovery of 3 MX, 1 MU, and 1,3DMU (Fig. 3). However, the in vitro reduction in P450 content was directly associated (r2 = 0.9101) with the in vivo decrease in urinary recovery of the total amount of theophylline metabolites, i.e., 3 MX + 1 MU + 1,3DMU, supporting that the in vivo repercussions of a viral infection on drug metabolism are associated to the ability of the serum of these volunteers to reduce P450 activity.



    Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The present study demonstrates that RSTIAR does not affect P450 amount or activity when incubated for 4 h with HCONT, however, it decreases P450 activity in HINFLA. When RSTIAR is incubated with HCONT for 24 h, P450 activity is reduced, as well as the amount of CYP3A6 protein. Incubation of RSTIAR with HINFLA for 24 h decreases total P450 content and activity, without affecting CYP1A1 or 1A2. Keeping in mind that theophylline is primarily biotransformed by CYP1A2 (Kurdi et al., 1999), these results show that RSTIAR elicits a dual effect on P450: it reduces the activity of CYP1A1 and 1A2, and down-regulates CYP3A6. RSTIAR effects on P450 depend upon the length of incubation, and the state of the hepatocytes, i.e., control or primed.

The RSTIAR-induced decrease in P450 activity could be a general phenomenon since the down-regulation of P450 isoforms by lipopolysaccharides is preceded by their inactivation (Sewer et al., 1998). Nitric oxide may have a pivotal role in P450 inactivation by both, the turpentine induced inflammation (El-Kadi et al., 2000), and lipopolysaccharide-induced endotoxemia (Sewer et al., 1998; Takemura et al., 1999). The fact that the biotransformation of theophylline and total P450 content in HINFLA are reduced by RSTIAR without changes in the amount of CYP1A1, 1A2, and 3A6 proteins, further supports that nitric oxide contributes to the reduction in P450 activity. As discussed, upon binding to Fe2+ and Fe3+-heme, nitric oxide impedes O2 binding and as a consequence, it reduces theophylline biotransformation. In parallel, nitric oxide binding to Fe2+-heme impedes the binding of carbon monoxide used for the spectrophotometric determination of total P450 content (Omura and Sato, 1964), resulting in the apparent decrease in total P450 content.

Following 24-h incubation with HCONT, RSTIAR reduction of P450 activity and CYP3A6 expression may be explained by the fact that IL-6 is the primary serum mediator induced by the TIAR (Bleau et al., 2000; Siewert et al., 2000). IL-6 preferentially depresses activity and expression of CYP3A, with little effect on the expression of CYP1A1 and 1A2 proteins (Muntané-Relat et al., 1995). CYP3A6 down-regulation by IL-6 has been associated with the decrease in the expression of pregnane X receptor and constitutively activated receptor mRNAs (Pascussi et al., 2000). On the other hand, it has been shown that IL-6 increases the expression of inducible nitric-oxide synthase (NOS2) (Ma and Zhu, 2000). Since CYP3A6 in HINFLA is already depressed by the TIAR, incubation of HINFLA with RSTIAR for 24 h reduces only CYP1A1 and 1A2 activity.

When HSURVI is incubated for 4 h with HCONT, there is a decrease in P450 activity without changes in CYP1A1, 1A2, or 3A6 apoproteins; when the incubation is prolonged for 24 h, the decrease in P450 activity is accompanied by a reduction in the amount of CYP3A6. Incubation of HSURVI with HINFLA for 4 h reduces activity and total P450 content, and incubation for 24 h reduces activity, total P450 content and amount of CYP1A1 and 1A2 proteins. These experiments clearly indicate that P450 down-regulation is preceded by a decrease in activity of several P450 isoforms. As demonstrated by the in vivo studies in human volunteers, the potency of HSURVI to reduce P450 activity is directly associated with the repercussions of the viral infection on the in vivo metabolism of theophylline.

There is evidence pointing out that following the incubation of HSURVI with HCONT and HINFLA for 4 h, the decrease in P450 activity is also mediated by nitric oxide (El-Kadi et al., 2000). The decrease in P450 activity in HCONT following 4-h incubation with HSURVI implies that the source of nitric oxide may not be NOS2, since longer periods are required to increase its expression. A potential source of nitric oxide in HCONT could be CYP3A6, since this isoform is a direct source of nitric oxide (Servent et al., 1989; Boucher et al., 1992). On the other hand, in HINFLA after 4 h of incubation, the effect of HSURVI is almost totally prevented by Nomega -nitro-L-arginine methyl ester (El-Kadi et al., 2000), supporting that nitric oxide is also responsible for the decrease in P450 activity. The source of nitric oxide in HINFLA could be NOS2, because CYP3A6 is almost completely down-regulated.

Following 24 h of incubation, HSURVI down-regulates CYP1A1/2 in HINFLA but not in HCONT, where only CYP3A6 is down-regulated. Possibly several factors associated to the density of surface receptors, the kind of cytokines stimulated by influenza, and the ability of these cytokines to depress selective P450 isoforms contribute to explain these differences. In HINFLA primed by the TIAR, the density of surface receptors to IFN-gamma , IL-1beta , TNF-alpha , and IL-6 could be increased, since not only inflammatory stimuli increase the density of surface receptors but also higher levels of circulating cytokines produce the same effect (Volpes et al., 1991; Dinarello, 1994). In humans, influenza increases the concentration of cytokines known to down-regulate P450 isoforms, such as IL-1beta , IL-6, TNF-alpha , and IFN-gamma (Han and Meydani, 2000). The ability of these cytokines to depress CYP3A isoforms is greater than that to down-regulate CYP1A1/2 (Abdel-Razzak et al., 1993; Muntané-Relat et al., 1995). These differences may be explained in part by the mechanism through which a cytokine depresses the expression of an isoform. For example, IL-1beta promotes a pretranscriptional repression, while IFN-gamma exerts a post-transcriptional suppressive effect on CYP3A6 expression (Calleja et al., 1998), and a pretranscriptional down-regulation of CYP1A2 (Abdel-Razzak et al., 1993), however, its effect is weak compared with IL-1beta (Calleja et al., 1997). IL-6 is a stronger pretranscriptional repressor of CYP3A4 mRNA than IL-1beta and TNF-alpha , but TNF-alpha appears to elicit a stronger pretranscriptional effect on CYP1A1/2 than IL-1beta and IL-6 (Muntané-Relat et al., 1995). We may postulate that CYP3A6 expression is more sensitive to the effect of cytokines because IL-1beta , IL-6, TNF-alpha , and IFN-gamma down-regulate CYP3A6 expression through pre- and post-transcriptional mechanisms, and CYP1A1/2 only by a pretranscriptional repression mechanism.

In conclusion, the present study demonstrates 1) that the effect of RSTIAR and HSURVI depends upon the susceptibility of the hepatocyte (HCONT or primed HINFLA), emphasizing the importance of the model for an accurate interpretation of the results; 2) that P450 down-regulation is preceded by a decrease in P450 activity; 3) that the differences between RSTIAR and HSURVI are primarily dependent upon the mediators contained in the serum, indicating that the nature of the inflammatory reaction is of importance to determine the repercussions on P450 activity and expression; and 4) the present results confirm that CYP3A6 is more vulnerable than CYP1A1 and 1A2 to the down-regulation provoked by an inflammatory challenge, a fact that may have practical consequences when it is taken into account the relevancy of this isoform in drug metabolism.

Anne-Marie Bleau
Caroline Fradette
Ayman O. S. El-Kadi
Marie-Claude Côté
Patrick du Souich

Department of Pharmacology, Faculty of Medicine, University of Montréal, Montréal, Québec, Canada

    Acknowledgments

The technical assistance of Hélène Mauriel and Lucie Héroux is gratefully acknowledged.

    Footnotes

Received December 12, 2000; accepted March 20, 2001.

This study was supported by a grant from the Canadian Institutes of Health Research (MOP-43925).

Patrick du Souich, M.D., Ph.D., Department of Pharmacology, Faculty of Medicine, University of Montréal, P.O. Box 6128, Stat. Center-Ville, Montréal, Québec, Canada H3C 3J7. E-mail: patrick.du.souich{at}umontreal.ca

    Abbreviations

Abbreviations used are: P450, cytochrome P450; IFN, interferon; CYP, apoprotein of the cytochrome P450; IL, interleukin; TNF-alpha , tumor necrosis factor-alpha ; HSURVI, serum from human with an upper respiratory viral infection; TIAR, turpentine-induced acute inflammatory reaction; RSTIAR, serum from rabbits with a turpentine-induced acute inflammatory reaction; HINFLA, hepatocytes from rabbit with a turpentine-induced acute inflammatory reaction; HCONT, hepatocytes from control rabbit; 3 MX, 3-methylxanthine; 1 MU, 1-methyluric acid; 1,3DMU, 1,3-dimethyluric acid; RSCONT, serum from control rabbits; HSCONT serum from control volunteers, URVI, upper respiratory viral infection; NOS, nitric-oxide synthase.


    References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References


0090-9556/01/2907-1007-1012
DMD, 29:1007-1012, 2001
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleau, A.-M.
Right arrow Articles by du Souich, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleau, A.-M.
Right arrow Articles by du Souich, P.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition